HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Correspondence: Submit a response Alert me when this article is cited Alert me when Correspondence are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hader, W. J. Articles by Yee, I. M.L. Search for Related Content PubMed PubMed Citation Articles by Hader, W. J. Articles by Yee, I. M.L. Related Collections Multiple sclerosis

Incidence and prevalence of multiple sclerosis in Saskatoon, Saskatchewan

From the Department of Physical Medicine and Rehabilitation (W.J.H.), University of Saskatchewan, Saskatoon, Saskatchewan, Canada; and the Faculty of Medicine (I.M.L.Y.), Department of Medical Genetics, University of British Columbia, Vancouver, Canada.

Address correspondence and reprint requests to Dr. Walter J. Hader, Saskatoon City Hospital, 701 Queen St., Saskatoon Saskatchewan, Canada S7K 0M7 walter.hader{at}saskatoonhealthregion.ca

Objective: To determine the incidence of multiple sclerosis (MS) in a longitudinal surveillance over 35 years and to estimate the prevalence rate in Saskatoon, Saskatchewan, on January 1, 2005.

Methods: A population-based registry was established in 1969, and identification of cases continued to 2005, from medical records, physicians, neurologists, community and provincial resources. A modified classification of Allison and Millar and the Schumacher diagnostic criteria were originally applied, and patients with definite and probable MS were included. The rates were age- and sex-adjusted to the US, European, and world 2000 populations.

Results: From 1970 to 2004, there were 558 incidence cases identified, 402 women and 156 men, for a sex ratio of 2.6:1 The average annual incidence rate was 9.5 in 100,000 (95% CI 8.8 to 10.4) and was stable over the three decades. The innate risk or residence at onset rate was 197 in 100,000 (95% CI 170 to 226). The crude prevalence rate for the living 587 cases on January 1, 2005, was 298.3 in 100,000 (95% CI 274.7 to 323.6).

Conclusions: The incidence and prevalence rates adjusted to the standardized populations were statistically higher than the longitudinal European studies and similar to North American studies. Our incidence study confirms the high risk of multiple sclerosis (MS) in Saskatoon, and these rates seem to be stable over the past 35 years. The high crude prevalence rate results from an accumulation of incidence and nonresident cases over time. Long-term follow-up studies and comparison with standardized populations are recommended to estimate reliable incidence and the true risk of MS in the world.

Abbreviations: MS = multiple sclerosis.

Disclosure: The authors report no conflicts of interest.

Received December 18, 2006. Accepted in final form April 17, 2007.

This article has been cited by other articles:

				I. Bostrom, M. Callander, J. F Kurtzke, and A.-M. Landtblom High prevalence of multiple sclerosis in the Swedish county of Varmland Multiple Sclerosis, November 1, 2009; 15(11): 1253 - 1262. [Abstract] [PDF]

				E. C. Klawiter, A. H. Cross, and R. T. Naismith The present efficacy of multiple sclerosis therapeutics: Is the new 66% just the old 33%? Neurology, September 22, 2009; 73(12): 984 - 990. [Abstract] [Full Text] [PDF]

				B. Beretich and T. Beretich Explaining multiple sclerosis prevalence by ultraviolet exposure: a geospatial analysis Multiple Sclerosis, August 1, 2009; 15(8): 891 - 898. [Abstract] [PDF]